You are here: Home » Reuters » News
Business Standard

Exclusive: Moderna mulls upsizing largest biotech IPO since 2016 - sources


By Lance Tupper and Joshua Franklin(Reuters) - Moderna Inc is considering selling up to 20 percent more shares than originally planned in its initial public offering on Thursday, allaying concerns that stock market jitters could derail the biggest flotation of a biotechnology company since 2016, two people familiar with the matter said. Moderna is set to price its IPO on Thursday evening following another turbulent day in the U.S. stock market, amid investor concerns over the trade dispute between the United States and China. The S&P 500 and the Dow Jones Industrial Average slipped back to ...

This article is no longer available in our repository.

There could be multiple reasons for this.

First Published: Fri, December 07 2018. 02:54 IST